Pharmafile Logo
Pharmafocus logo
Advanced Search

Vetter announces leadership transition as Thomas Otto retires

December 5, 2025
Managing Director, Vetter

Vetter has announced the retirement of managing director Thomas Otto amid strategic plans for restructuring its management team. Otto has …

Appointment

Samsung Bioepis announces launch of two new denosumab biosimilars in Europe

December 4, 2025
Sales and Marketing Oncology, Osteoporosis, Samsung Bioepis

Samsung Bioepis has announced the European launch of Obodence and Xbryk, two new denosumab biosimilars approved for the treatment of …

News

Medicus Pharma appoints Carolyn Bonner as CFO

December 4, 2025
Medicus Pharma, chief financial officer

Medicus Pharma has announced the appointment of Carolyn Bonner as Chief Financial Officer (CFO) in addition to her role as …

Appointment

Sandoz launches two new bone disease biosimilars in Europe

December 3, 2025
Sales and Marketing Oncology, Osteoporosis, Sandoz

Sandoz has announced the European launch of two new bone disease biosimilars. Wyost (denosumab 120 mg) is approved for the …

News

Faron Pharmaceuticals appoints Jurriaan Dekkers as Chief Financial Officer

December 3, 2025
Faron Pharmaceuticals, chief financial officer

Faron Pharmaceuticals, a clinical-stage biopharmaceutical company, has appointed Jurriaan Dekkers as its new Chief Financial Officer (CFO). Dekkers most recently …

Appointment

Medicus Pharma shares updates on basal cell carcinoma trials

December 2, 2025
Research and Development Medicus Pharma, Oncology

Medicus Pharma has announced updates on the progress of SKNJCT-003 and SKNJCT-004, its clinical trials studying the efficacy of a …

News

Arnold & Porter appoints George Jenkins as partner

December 2, 2025
Arnold & Porter, law, life sciences

Arnold & Porter has announced the appointment of George Jenkins as a partner in the firm’s Corporate & Finance practice. …

Appointment

Safeguarding health and well-being for employees – the value of occupational health services

December 1, 2025
Medical Communications Chartered Institute of Personnel and Development, Society of Occupational Medicine, employee health and well-being, occupational health, workplace sickness absence levels

With workplace sickness absence levels stuck at record levels, employers need to step-change how they think about and manage employee …

Feature

Men’s health – a new report from the Department of Health and Social Care

November 28, 2025
Medical Communications Men's Health Strategy, Men's mental health, UK Department of Health and Social Care, medical communications, medical education, mental health

The UK Department of Health and Social Care has published a new report entitled Men’s health: a strategic vision for …

Feature

Healing the fracture in the system: the case for universal fraction liaison services access

November 28, 2025
Medical Communications, Research and Development Osteoporosis

By Tina Backhouse In 2024, the UK government committed to achieving 100% coverage of Fracture Liaison Services (FLS)across the NHS …

Feature

Five Facts about antimicrobial resistance

November 28, 2025
Medical Communications Antimicrobial resistance (AMR), Five Facts

1 Antimicrobial resistance (AMR) is when bacteria, viruses, fungi and parasites no longer respond to antimicrobial agents such as antibiotics.1 Around 35,000 …

Feature

Celltrion’s Remsima IV approved by EC in liquid form

November 27, 2025
Research and Development Celltrion Inc, Immunology

Celltrion’s Remsima IV, the first-ever liquid formulation of infliximab for autoimmune diseases, has been approved by the European Commission (EC). …

News

One-carbon Therapeutics starts new cancer therapy trial

November 27, 2025
Research and Development Oncology, One-carbon Therapeutics

Clinical-stage biotechnology company One-carbon Therapeutics has announced that the first subject has been dosed in its clinical trial for TH9619, …

News

Major breakthrough in T-cell receptor therapy manufacturing

November 27, 2025
Manufacturing and Production Terumo BCT, cell therapy

For the first time, researchers at the University of Chicago in the US have successfully completed all three critical steps …

News

Gilead announces first shipments of HIV prevention drug to Eswatini and Zambia

November 27, 2025
Product launch Gilead, HIV/AIDS

Gilead has announced the first shipments of its HIV prevention drug lenacapavir to Eswatini and Zambia, a milestone in the …

News

InnotiveDx gets £1m grant to advance UTI diagnostics system

November 27, 2025
Research and Development Diagnostics, InnotiveDx, Urology

InnotiveDx has announced that it has received a £1m grant from Pathways to Antimicrobial Clinical Efficacy (PACE) to advance the …

News

Cellbyte raises $2.75m to fund pharma drug launch platform

November 27, 2025
Product launch AI, Cellbyte, biotech

Cellbyte has announced that it has raised $2.75m in seed funding for the streamlining of pharmaceutical drug launches. The complexity …

News

Accession Therapeutics doses first patient in new cancer immunotherapy trial

November 26, 2025
Research and Development Accession Therapeutics, Oncology

Biopharmaceutical company Accession Therapeutics has announced the dosing of the first patient in the phase 1 clinical trial of TROCEPT-01 …

News
Press release

ViVac Pharma appoints Keren Leshem as CEO

November 26, 2025
CEO, Oncology, ViVac Pharma

Early-stage biotechnology company ViVac Pharma has appointed Keren Leshem as its new CEO. Leshem brings almost 30 years of experience …

Appointment

Alvotech biosimilar receives EC marketing approval

November 26, 2025
Research and Development Alvotech, Immunology, Inflammatory disease, Rheumatology

The European Commission (EC) has granted marketing authorisation for Gobivaz, Alvotech’s first-in-market biosimilar of Simponi (golimumab), which is used for …

News
The Gateway to Local Adoption Series

Latest content

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026

PSI appoints David Allen as Country Manager for Canada

January 22, 2026

Qureight appoints Steven Bishop as Chief Medical Officer

January 21, 2026

Pierre Fabre Laboratories and Iktos announce oncology collaboration

January 21, 2026

Qureight appoints Rebecca Simmons as Chief Operating Officer

January 20, 2026